Evaluation of cytokeratin markers to differentiate between benign and malignant prostatic tissue

P. Guinan, M. Shaw, P. Targonski, V. Ray, M. Rubenstein

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Cytokeratins are intermediate filaments found within basal and secretory epithelial cells. Antisera raised against cytokeratins were available but frequently differ in specificity. Many are incompletely characterized for their reactivity against epithelial components. Cytokeratin (Cyto) P is a polyclonal antisera specific for 56 and 64 kd cytokeratins. Cyto M is a pool of monoclonals reacting against 40, 46, 50, 52, 58, and 65-67 kd cytokeratins. Initially, utilizing immunohistologic techniques, we evaluated these two antisera for their ability to distinguish between prostatic tissues of benign (benign prostatic hypertrophy [BPH]) or malignant (carcinoma of the prostate [CAP]) origin in the 34 cases evaluated. Specimens were analyzed for both Cyto P and Cyto M reactivity, as well as for the degree of reactivity. Lastly, in an effort to determine the morphologic relationship of atypical hyperplasia (AH) with either BPH or CAP, nine additional prostate specimens were analyzed. Cyto P was reactive in 8 of 8 (100%) BPH specimens and in 2 of 26 (8%) CAP specimens. Mean Cyto P degree of reactivity in the positive specimens was greater in BPH than in CAP (2.6 vs. 1.0). Cyto M reactivity was present in 8 of 8 (100%) BPH specimens and in 23 of 25 (92%) CAP specimens. Mean Cyto M degree of reactivity in the positive specimens was greater in CAP than in BPH (3.6 vs. 2.8). Cyto P was reactive in 3 of 9 (33%) AH specimens, with a mean degree of reactivity of 2.7. Cyto M was reactive in 9 of 9 (100%) AH specimens, with a mean degree of reactivity of 3.9. Cyto P reacted with only the basal cells, whereas Cyto M reacted with basal as well as secretory cells. These differences appeared to be the result of the differential reactivity of basal cells, which are present in BPH but absent in CAP. In summary, Cyto P and Cyto M are potentially useful markers in differentiating BPH from CAP, and it appears that AH is immunohistopathologically related to both.

Original languageEnglish (US)
Pages (from-to)175-180
Number of pages6
JournalJournal of Surgical Oncology
Volume42
Issue number3
StatePublished - 1989
Externally publishedYes

Fingerprint

Keratins
Prostatic Hyperplasia
Prostate
Carcinoma
Hyperplasia
Immune Sera
Intermediate Filaments

ASJC Scopus subject areas

  • Oncology
  • Surgery

Cite this

Guinan, P., Shaw, M., Targonski, P., Ray, V., & Rubenstein, M. (1989). Evaluation of cytokeratin markers to differentiate between benign and malignant prostatic tissue. Journal of Surgical Oncology, 42(3), 175-180.

Evaluation of cytokeratin markers to differentiate between benign and malignant prostatic tissue. / Guinan, P.; Shaw, M.; Targonski, P.; Ray, V.; Rubenstein, M.

In: Journal of Surgical Oncology, Vol. 42, No. 3, 1989, p. 175-180.

Research output: Contribution to journalArticle

Guinan, P, Shaw, M, Targonski, P, Ray, V & Rubenstein, M 1989, 'Evaluation of cytokeratin markers to differentiate between benign and malignant prostatic tissue', Journal of Surgical Oncology, vol. 42, no. 3, pp. 175-180.
Guinan, P. ; Shaw, M. ; Targonski, P. ; Ray, V. ; Rubenstein, M. / Evaluation of cytokeratin markers to differentiate between benign and malignant prostatic tissue. In: Journal of Surgical Oncology. 1989 ; Vol. 42, No. 3. pp. 175-180.
@article{38ebed2a7394413fb755f135f46d614e,
title = "Evaluation of cytokeratin markers to differentiate between benign and malignant prostatic tissue",
abstract = "Cytokeratins are intermediate filaments found within basal and secretory epithelial cells. Antisera raised against cytokeratins were available but frequently differ in specificity. Many are incompletely characterized for their reactivity against epithelial components. Cytokeratin (Cyto) P is a polyclonal antisera specific for 56 and 64 kd cytokeratins. Cyto M is a pool of monoclonals reacting against 40, 46, 50, 52, 58, and 65-67 kd cytokeratins. Initially, utilizing immunohistologic techniques, we evaluated these two antisera for their ability to distinguish between prostatic tissues of benign (benign prostatic hypertrophy [BPH]) or malignant (carcinoma of the prostate [CAP]) origin in the 34 cases evaluated. Specimens were analyzed for both Cyto P and Cyto M reactivity, as well as for the degree of reactivity. Lastly, in an effort to determine the morphologic relationship of atypical hyperplasia (AH) with either BPH or CAP, nine additional prostate specimens were analyzed. Cyto P was reactive in 8 of 8 (100{\%}) BPH specimens and in 2 of 26 (8{\%}) CAP specimens. Mean Cyto P degree of reactivity in the positive specimens was greater in BPH than in CAP (2.6 vs. 1.0). Cyto M reactivity was present in 8 of 8 (100{\%}) BPH specimens and in 23 of 25 (92{\%}) CAP specimens. Mean Cyto M degree of reactivity in the positive specimens was greater in CAP than in BPH (3.6 vs. 2.8). Cyto P was reactive in 3 of 9 (33{\%}) AH specimens, with a mean degree of reactivity of 2.7. Cyto M was reactive in 9 of 9 (100{\%}) AH specimens, with a mean degree of reactivity of 3.9. Cyto P reacted with only the basal cells, whereas Cyto M reacted with basal as well as secretory cells. These differences appeared to be the result of the differential reactivity of basal cells, which are present in BPH but absent in CAP. In summary, Cyto P and Cyto M are potentially useful markers in differentiating BPH from CAP, and it appears that AH is immunohistopathologically related to both.",
author = "P. Guinan and M. Shaw and P. Targonski and V. Ray and M. Rubenstein",
year = "1989",
language = "English (US)",
volume = "42",
pages = "175--180",
journal = "Journal of Surgical Oncology",
issn = "0022-4790",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Evaluation of cytokeratin markers to differentiate between benign and malignant prostatic tissue

AU - Guinan, P.

AU - Shaw, M.

AU - Targonski, P.

AU - Ray, V.

AU - Rubenstein, M.

PY - 1989

Y1 - 1989

N2 - Cytokeratins are intermediate filaments found within basal and secretory epithelial cells. Antisera raised against cytokeratins were available but frequently differ in specificity. Many are incompletely characterized for their reactivity against epithelial components. Cytokeratin (Cyto) P is a polyclonal antisera specific for 56 and 64 kd cytokeratins. Cyto M is a pool of monoclonals reacting against 40, 46, 50, 52, 58, and 65-67 kd cytokeratins. Initially, utilizing immunohistologic techniques, we evaluated these two antisera for their ability to distinguish between prostatic tissues of benign (benign prostatic hypertrophy [BPH]) or malignant (carcinoma of the prostate [CAP]) origin in the 34 cases evaluated. Specimens were analyzed for both Cyto P and Cyto M reactivity, as well as for the degree of reactivity. Lastly, in an effort to determine the morphologic relationship of atypical hyperplasia (AH) with either BPH or CAP, nine additional prostate specimens were analyzed. Cyto P was reactive in 8 of 8 (100%) BPH specimens and in 2 of 26 (8%) CAP specimens. Mean Cyto P degree of reactivity in the positive specimens was greater in BPH than in CAP (2.6 vs. 1.0). Cyto M reactivity was present in 8 of 8 (100%) BPH specimens and in 23 of 25 (92%) CAP specimens. Mean Cyto M degree of reactivity in the positive specimens was greater in CAP than in BPH (3.6 vs. 2.8). Cyto P was reactive in 3 of 9 (33%) AH specimens, with a mean degree of reactivity of 2.7. Cyto M was reactive in 9 of 9 (100%) AH specimens, with a mean degree of reactivity of 3.9. Cyto P reacted with only the basal cells, whereas Cyto M reacted with basal as well as secretory cells. These differences appeared to be the result of the differential reactivity of basal cells, which are present in BPH but absent in CAP. In summary, Cyto P and Cyto M are potentially useful markers in differentiating BPH from CAP, and it appears that AH is immunohistopathologically related to both.

AB - Cytokeratins are intermediate filaments found within basal and secretory epithelial cells. Antisera raised against cytokeratins were available but frequently differ in specificity. Many are incompletely characterized for their reactivity against epithelial components. Cytokeratin (Cyto) P is a polyclonal antisera specific for 56 and 64 kd cytokeratins. Cyto M is a pool of monoclonals reacting against 40, 46, 50, 52, 58, and 65-67 kd cytokeratins. Initially, utilizing immunohistologic techniques, we evaluated these two antisera for their ability to distinguish between prostatic tissues of benign (benign prostatic hypertrophy [BPH]) or malignant (carcinoma of the prostate [CAP]) origin in the 34 cases evaluated. Specimens were analyzed for both Cyto P and Cyto M reactivity, as well as for the degree of reactivity. Lastly, in an effort to determine the morphologic relationship of atypical hyperplasia (AH) with either BPH or CAP, nine additional prostate specimens were analyzed. Cyto P was reactive in 8 of 8 (100%) BPH specimens and in 2 of 26 (8%) CAP specimens. Mean Cyto P degree of reactivity in the positive specimens was greater in BPH than in CAP (2.6 vs. 1.0). Cyto M reactivity was present in 8 of 8 (100%) BPH specimens and in 23 of 25 (92%) CAP specimens. Mean Cyto M degree of reactivity in the positive specimens was greater in CAP than in BPH (3.6 vs. 2.8). Cyto P was reactive in 3 of 9 (33%) AH specimens, with a mean degree of reactivity of 2.7. Cyto M was reactive in 9 of 9 (100%) AH specimens, with a mean degree of reactivity of 3.9. Cyto P reacted with only the basal cells, whereas Cyto M reacted with basal as well as secretory cells. These differences appeared to be the result of the differential reactivity of basal cells, which are present in BPH but absent in CAP. In summary, Cyto P and Cyto M are potentially useful markers in differentiating BPH from CAP, and it appears that AH is immunohistopathologically related to both.

UR - http://www.scopus.com/inward/record.url?scp=0024325204&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024325204&partnerID=8YFLogxK

M3 - Article

C2 - 2478835

AN - SCOPUS:0024325204

VL - 42

SP - 175

EP - 180

JO - Journal of Surgical Oncology

JF - Journal of Surgical Oncology

SN - 0022-4790

IS - 3

ER -